DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses-Reference-Cited by-同舟云学术

DICE: A Bayesian model for early dose finding in phase I trials with multiple treatment courses

Published:2021-11-02 Issue: Volume: Page:
ISSN:0323-3847
Container-title:Biometrical Journal
language:en
Short-container-title:Biometrical Journal

Author:

Ursino Moreno¹²³^ORCID,Biard Lucie⁴^ORCID,Chevret Sylvie⁴

Affiliation:

1. Centre de Recherche des Cordeliers INSERM Sorbonne Université USPC Université de Paris Paris France

2. Inria HeKA Paris France

3. Unit of Clinical Epidemiology Assistance Publique‐Hp̂itaux de Paris CHU Robert Debré Université de Paris Sorbonne Paris‐Cité INSERM CIC‐EC 1426 Paris France

4. Hôpital Saint Louis Service de Biostatistique et Information Médicale, INSERM U1153 Team ECSTRRA Université de Paris, AP‐HP Paris France

Publisher

Wiley

Subject

Statistics, Probability and Uncertainty,General Medicine,Statistics and Probability

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/bimj.202000369

Reference22 articles.

1. Simultaneously optimizing dose and schedule of a new cytotoxic agent;Braun T. M.;Clinical Trials,2007

2. Determining a maximum‐tolerated schedule of a cytotoxic agent;Braun T. M.;Biometrics,2005

3. A modeling framework to characterize cytokine release upon T‐cell–engaging bispecific antibody treatment: Methodology and opportunities;Chen X.;Clinical and Translational Science,2019

4. Sequential designs for phase I clinical trials with late‐onset toxicities;Cheung Y.;Biometrics,2000

5. Dose Finding by the Continual Reassessment Method

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose optimization for cancer treatments with considerations for late-onset toxicities;Clinical Trials;2024-04-09